Physician profile
Dell P Smith
NPI 1770589814
$7,147.55
in general payments reported to CMS, 2019-2025
14 companies · $13.69 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,218 · 2020: $154 · 2021: $101 · 2022: $229 · 2023: $220 · 2024: $212 · 2025: $13.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,511.76 | 2019-2022 | |
| Abbvie INC. | $283.91 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Mentor Worldwide LLC | $113.24 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Stratafix |
| Davol INC. | $42.49 | 2020-2021 | |
| Depuy Synthes Sales INC. | $37.22 | 2022 | |
| Sientra, INC. | $26.47 | 2020 | |
| Tela Bio, INC. | $24.36 | 2024 | Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $19.29 | 2022 | |
| Ethicon US, LLC | $17.19 | 2023 | Stratafix |
| Kci USA, INC. | $16.80 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $16.49 | 2024 | |
| Solventum Corporation | $15.26 | 2024 | 3m Cavilon, Activ.A.C. |
| Endo Pharmaceuticals INC. | $13.03 | 2021 | |
| Apyx Medical Corporation | $10.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dell Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.